Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

liver

  • Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After <sup>90</sup>Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity
    You have access
    Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After 90Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity
    Matthew M. Cousins, Theresa P. Devasia, Christopher M. Maurino, Justin Mikell, Matthew J. Schipper, Ravi K. Kaza, Theodore. S. Lawrence, Kyle C. Cuneo and Yuni K. Dewaraja
    Journal of Nuclear Medicine June 1, 2022, 63 (6) 882-889; DOI: https://doi.org/10.2967/jnumed.121.262447
  • You have access
    Treatment of Primary Liver Tumors and Liver Metastases, Part 2: Non–Nuclear Medicine Techniques
    Francois H. Cornelis and Stephen B. Solomon
    Journal of Nuclear Medicine December 1, 2018, 59 (12) 1801-1808; DOI: https://doi.org/10.2967/jnumed.116.186379
  • You have access
    Efficacy of Radioembolization with 166Ho-Microspheres in Salvage Patients with Liver Metastases: A Phase 2 Study
    Jip F. Prince, Maurice A.A.J. van den Bosch, Johannes F.W. Nijsen, Maarten L.J. Smits, Andor F. van den Hoven, Stavros Nikolakopoulos, Frank J. Wessels, Rutger C.G. Bruijnen, Manon N.G.J.A. Braat, Bernard A. Zonnenberg and Marnix G.E.H. Lam
    Journal of Nuclear Medicine April 1, 2018, 59 (4) 582-588; DOI: https://doi.org/10.2967/jnumed.117.197194
  • You have access
    Glypican-3–Targeted 89Zr PET Imaging of Hepatocellular Carcinoma
    Jonathan G. Sham, Forrest M. Kievit, John R. Grierson, Robert S. Miyaoka, Matthew M. Yeh, Miqin Zhang, Raymond S. Yeung, Satoshi Minoshima and James O. Park
    Journal of Nuclear Medicine May 1, 2014, 55 (5) 799-804; DOI: https://doi.org/10.2967/jnumed.113.132118
  • You have access
    99mTc-Macroaggregated Albumin Poorly Predicts the Intrahepatic Distribution of 90Y Resin Microspheres in Hepatic Radioembolization
    Maurits Wondergem, Maarten L.J. Smits, Mattijs Elschot, Hugo W.A.M. de Jong, Helena M. Verkooijen, Maurice A.A.J. van den Bosch, Johannes F.W. Nijsen and Marnix G.E.H. Lam
    Journal of Nuclear Medicine August 1, 2013, 54 (8) 1294-1301; DOI: https://doi.org/10.2967/jnumed.112.117614
  • You have access
    Early Dynamic 18F-FDG PET to Detect Hyperperfusion in Hepatocellular Carcinoma Liver Lesions
    Jan-Henning Schierz, Thomas Opfermann, Jörg Steenbeck, Eric Lopatta, Utz Settmacher, Andreas Stallmach, Robert J. Marlowe and Martin Freesmeyer
    Journal of Nuclear Medicine June 1, 2013, 54 (6) 848-854; DOI: https://doi.org/10.2967/jnumed.112.113936
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire